APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Sustained-Release Tablet

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Felodipine Sustained-Release Tablet Industry Growth and Trends Forecast to 2032

31 December 202596 pages

Choose your research edition.

Industry ResearchFelodipine Sustained-Release Tablet Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Sustained-Release Tablet Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Felodipine Sustained-Release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Sustained-Release Tablet Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Sustained-Release Tablet Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Sustained-Release Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Felodipine Sustained-Release Tablet include SHANXI KANGBO BIOLOGICAL PRODUCT, Sandoz, NanJing Easeheal Phaemaecutical, Mylan, Lifeon, Changzhou Siyao Pharmaceutical and Astrazeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Felodipine Sustained-Release Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Felodipine Sustained-Release Tablet market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Felodipine Sustained-Release Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Felodipine Sustained-Release Tablet.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Felodipine Sustained-Release Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Felodipine Sustained-Release Tablet Market by Company

SHANXI KANGBO BIOLOGICAL PRODUCT

Sandoz

NanJing Easeheal Phaemaecutical

Mylan

Lifeon

Changzhou Siyao Pharmaceutical

Astrazeneca

Felodipine Sustained-Release Tablet Segment by Type

2.5mg Per Tablet

5mg Per Tablet

Others

Felodipine Sustained-Release Tablet Segment by Application

Treat High Blood Pressure

Relieve Angina

Others

Felodipine Sustained-Release Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Sustained-Release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Sustained-Release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Sustained-Release Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Felodipine Sustained-Release Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Felodipine Sustained-Release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2.5mg Per Tablet Table 2. Major Company of 5mg Per Tablet Table 3. Major Company of Others Table 4. Global Felodipine Sustained-Release Tablet Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 6. Global Felodipine Sustained-Release Tablet Sales Market Share in Volume by Type (2021-2026) Table 7. Global Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (US$ Million) Table 8. Global Felodipine Sustained-Release Tablet Sales Market Share in Value by Type (2021-2026) Table 9. Global Felodipine Sustained-Release Tablet Price by Type (2021-2026) & (US$/Unit) Table 10. Global Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 11. Global Felodipine Sustained-Release Tablet Sales Market Share in Volume by Type (2027-2032) Table 12. Global Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (US$ Million) Table 13. Global Felodipine Sustained-Release Tablet Sales Market Share in Value by Type (2027-2032) Table 14. Global Felodipine Sustained-Release Tablet Price by Type (2027-2032) & (US$/Unit) Table 15. North America Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 16. North America Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 18. Europe Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 22. Latin America Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (US$ Million) Table 25. Felodipine Sustained-Release Tablet Industry Trends Table 26. Felodipine Sustained-Release Tablet Industry Drivers Table 27. Felodipine Sustained-Release Tablet Industry Opportunities and Challenges Table 28. Felodipine Sustained-Release Tablet Industry Restraints Table 29. Global Felodipine Sustained-Release Tablet Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2021-2026) Table 31. Global Felodipine Sustained-Release Tablet Sales by Company (2021-2026) & (K Units) Table 32. Global Felodipine Sustained-Release Tablet Sales Share by Company (2021-2026) Table 33. Global Felodipine Sustained-Release Tablet Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Felodipine Sustained-Release Tablet Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Felodipine Sustained-Release Tablet Major Company Production Sites and Headquarters Table 36. Global Felodipine Sustained-Release Tablet Company, Product Type & Application Table 37. Global Felodipine Sustained-Release Tablet Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Felodipine Sustained-Release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Felodipine Sustained-Release Tablet Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Felodipine Sustained-Release Tablet Sales by Region (2021-2026) & (K Units) Table 42. Global Felodipine Sustained-Release Tablet Sales Market Share in Volume by Region (2021-2026) Table 43. Global Felodipine Sustained-Release Tablet Sales by Region (2021-2026) & (US$ Million) Table 44. Global Felodipine Sustained-Release Tablet Sales Market Share in Value by Region (2021-2026) Table 45. Global Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Felodipine Sustained-Release Tablet Sales by Region (2027-2032) & (K Units) Table 47. Global Felodipine Sustained-Release Tablet Sales Market Share in Volume by Region (2027-2032) Table 48. Global Felodipine Sustained-Release Tablet Sales by Region (2027-2032) & (US$ Million) Table 49. Global Felodipine Sustained-Release Tablet Sales Market Share in Value by Region (2027-2032) Table 50. Global Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Felodipine Sustained-Release Tablet Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 53. Global Felodipine Sustained-Release Tablet Sales Market Share in Volume by Application (2021-2026) Table 54. Global Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (US$ Million) Table 55. Global Felodipine Sustained-Release Tablet Sales Market Share in Value by Application (2021-2026) Table 56. Global Felodipine Sustained-Release Tablet Price by Application (2021-2026) & (US$/Unit) Table 57. Global Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 58. Global Felodipine Sustained-Release Tablet Sales Market Share in Volume by Application (2027-2032) Table 59. Global Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (US$ Million) Table 60. Global Felodipine Sustained-Release Tablet Sales Market Share in Value by Application (2027-2032) Table 61. Global Felodipine Sustained-Release Tablet Price by Application (2027-2032) & (US$/Unit) Table 62. North America Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 63. North America Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 65. Europe Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 69. Latin America Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (US$ Million) Table 72. SHANXI KANGBO BIOLOGICAL PRODUCT Company Information Table 73. SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview Table 74. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio Table 76. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Development Table 77. Sandoz Company Information Table 78. Sandoz Business Overview Table 79. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sandoz Felodipine Sustained-Release Tablet Product Portfolio Table 81. Sandoz Recent Development Table 82. NanJing Easeheal Phaemaecutical Company Information Table 83. NanJing Easeheal Phaemaecutical Business Overview Table 84. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio Table 86. NanJing Easeheal Phaemaecutical Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mylan Felodipine Sustained-Release Tablet Product Portfolio Table 91. Mylan Recent Development Table 92. Lifeon Company Information Table 93. Lifeon Business Overview Table 94. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Lifeon Felodipine Sustained-Release Tablet Product Portfolio Table 96. Lifeon Recent Development Table 97. Changzhou Siyao Pharmaceutical Company Information Table 98. Changzhou Siyao Pharmaceutical Business Overview Table 99. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio Table 101. Changzhou Siyao Pharmaceutical Recent Development Table 102. Astrazeneca Company Information Table 103. Astrazeneca Business Overview Table 104. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio Table 106. Astrazeneca Recent Development Table 107. North America Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 109. North America Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2026) Table 110. North America Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Felodipine Sustained-Release Tablet Sales Market Share Forecast by Country (2027-2032) Table 112. North America Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Felodipine Sustained-Release Tablet Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Felodipine Sustained-Release Tablet Market Share by Country (2021-2026) Table 115. North America Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Felodipine Sustained-Release Tablet Market Share Forecast by Country (2027-2032) Table 117. Europe Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 119. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2026) Table 120. Europe Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Felodipine Sustained-Release Tablet Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Felodipine Sustained-Release Tablet Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Felodipine Sustained-Release Tablet Market Share by Country (2021-2026) Table 125. Europe Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Felodipine Sustained-Release Tablet Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Felodipine Sustained-Release Tablet Market Share by Country (2021-2026) Table 135. Asia-Pacific Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Felodipine Sustained-Release Tablet Market Share Forecast by Country (2027-2032) Table 137. Latin America Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 139. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2026) Table 140. Latin America Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Felodipine Sustained-Release Tablet Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Felodipine Sustained-Release Tablet Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Felodipine Sustained-Release Tablet Market Share by Country (2021-2026) Table 145. Latin America Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Felodipine Sustained-Release Tablet Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Felodipine Sustained-Release Tablet Market Share by Country (2021-2026) Table 155. Middle East and Africa Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Felodipine Sustained-Release Tablet Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Felodipine Sustained-Release Tablet Distributors List Table 160. Felodipine Sustained-Release Tablet Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Felodipine Sustained-Release Tablet Image Figure 2. Global Felodipine Sustained-Release Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Sustained-Release Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Felodipine Sustained-Release Tablet Sales (2021-2032) & (K Units) Figure 5. 2.5mg Per Tablet Image Figure 6. Global 2.5mg Per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5mg Per Tablet Image Figure 8. Global 5mg Per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Felodipine Sustained-Release Tablet Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Felodipine Sustained-Release Tablet Market Share by Type 2025 VS 2032 Figure 13. North America Felodipine Sustained-Release Tablet Sales Market Share in Volume by Type in 2025 Figure 14. North America Felodipine Sustained-Release Tablet Sales Market Share in Value by Type in 2025 Figure 15. Europe Felodipine Sustained-Release Tablet Sales Market Share in Volume by Type in 2025 Figure 16. Europe Felodipine Sustained-Release Tablet Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share in Value by Type in 2025 Figure 19. Latin America Felodipine Sustained-Release Tablet Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Felodipine Sustained-Release Tablet Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Felodipine Sustained-Release Tablet Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Treat High Blood Pressure Image Figure 26. Global Treat High Blood Pressure Sales YoY Growth (2021-2032) & (K Units) Figure 27. Relieve Angina Image Figure 28. Global Relieve Angina Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Felodipine Sustained-Release Tablet Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Felodipine Sustained-Release Tablet Market Share by Application 2025 VS 2032 Figure 33. North America Felodipine Sustained-Release Tablet Sales Market Share in Volume by Application in 2025 Figure 34. North America Felodipine Sustained-Release Tablet Sales Market Share in Value by Application in 2025 Figure 35. Europe Felodipine Sustained-Release Tablet Sales Market Share in Volume by Application in 2025 Figure 36. Europe Felodipine Sustained-Release Tablet Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Felodipine Sustained-Release Tablet Sales Market Share in Value by Application in 2025 Figure 39. Latin America Felodipine Sustained-Release Tablet Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Felodipine Sustained-Release Tablet Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share in Value by Application in 2025 Figure 43. North America Felodipine Sustained-Release Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Felodipine Sustained-Release Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Felodipine Sustained-Release Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Felodipine Sustained-Release Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Felodipine Sustained-Release Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Felodipine Sustained-Release Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Felodipine Sustained-Release Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Felodipine Sustained-Release Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Felodipine Sustained-Release Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Felodipine Sustained-Release Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Felodipine Sustained-Release Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Felodipine Sustained-Release Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Felodipine Sustained-Release Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Felodipine Sustained-Release Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Felodipine Sustained-Release Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Felodipine Sustained-Release Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Felodipine Sustained-Release Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Felodipine Sustained-Release Tablet Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Felodipine Sustained-Release Tablet Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg Per Tablet
  • 5mg Per Tablet
  • Others
Applications
  • Treat High Blood Pressure
  • Relieve Angina
  • Others
Companies covered
  • SHANXI KANGBO BIOLOGICAL PRODUCT
  • Sandoz
  • NanJing Easeheal Phaemaecutical
  • Mylan
  • Lifeon
  • Changzhou Siyao Pharmaceutical
  • Astrazeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Felodipine Sustained-Release Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Felodipine Sustained-Release Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Felodipine Sustained-Release Tablet Market by Type
  6. 1.3.1 2.5mg Per Tablet
  7. 1.3.2 5mg Per Tablet
  8. 1.3.3 Others
  9. 1.4 Global Felodipine Sustained-Release Tablet Market Size by Type
  10. 1.4.1 Global Felodipine Sustained-Release Tablet Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Felodipine Sustained-Release Tablet Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Felodipine Sustained-Release Tablet Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Felodipine Sustained-Release Tablet Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Felodipine Sustained-Release Tablet Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Felodipine Sustained-Release Tablet Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Felodipine Sustained-Release Tablet Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Felodipine Sustained-Release Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Felodipine Sustained-Release Tablet Industry Trends
  2. 2.2 Felodipine Sustained-Release Tablet Industry Drivers
  3. 2.3 Felodipine Sustained-Release Tablet Industry Opportunities and Challenges
  4. 2.4 Felodipine Sustained-Release Tablet Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Felodipine Sustained-Release Tablet Revenue (2021-2026)
  2. 3.2 Global Top Players by Felodipine Sustained-Release Tablet Sales (2021-2026)
  3. 3.3 Global Top Players by Felodipine Sustained-Release Tablet Price (2021-2026)
  4. 3.4 Global Felodipine Sustained-Release Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Felodipine Sustained-Release Tablet Major Company Production Sites & Headquarters
  6. 3.6 Global Felodipine Sustained-Release Tablet Company, Product Type & Application
  7. 3.7 Global Felodipine Sustained-Release Tablet Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Felodipine Sustained-Release Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Felodipine Sustained-Release Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Felodipine Sustained-Release Tablet Tier 1, Tier 2, and Tier 3
4 Felodipine Sustained-Release Tablet Regional Status and Outlook
  1. 4.1 Global Felodipine Sustained-Release Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Felodipine Sustained-Release Tablet Historic Market Size by Region
  3. 4.2.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Felodipine Sustained-Release Tablet Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Felodipine Sustained-Release Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Felodipine Sustained-Release Tablet Forecasted Market Size by Region
  7. 4.3.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Felodipine Sustained-Release Tablet Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Felodipine Sustained-Release Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Felodipine Sustained-Release Tablet by Application
  1. 5.1 Felodipine Sustained-Release Tablet Market by Application
  2. 5.1.1 Treat High Blood Pressure
  3. 5.1.2 Relieve Angina
  4. 5.1.3 Others
  5. 5.2 Global Felodipine Sustained-Release Tablet Market Size by Application
  6. 5.2.1 Global Felodipine Sustained-Release Tablet Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Felodipine Sustained-Release Tablet Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Felodipine Sustained-Release Tablet Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Felodipine Sustained-Release Tablet Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Felodipine Sustained-Release Tablet Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Felodipine Sustained-Release Tablet Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Felodipine Sustained-Release Tablet Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Felodipine Sustained-Release Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 SHANXI KANGBO BIOLOGICAL PRODUCT
  2. 6.1.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
  3. 6.1.2 SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview
  4. 6.1.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio
  6. 6.1.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Felodipine Sustained-Release Tablet Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 NanJing Easeheal Phaemaecutical
  14. 6.3.1 NanJing Easeheal Phaemaecutical Company Information
  15. 6.3.2 NanJing Easeheal Phaemaecutical Business Overview
  16. 6.3.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio
  18. 6.3.5 NanJing Easeheal Phaemaecutical Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Felodipine Sustained-Release Tablet Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Lifeon
  26. 6.5.1 Lifeon Company Information
  27. 6.5.2 Lifeon Business Overview
  28. 6.5.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lifeon Felodipine Sustained-Release Tablet Product Portfolio
  30. 6.5.5 Lifeon Recent Developments
  31. 6.6 Changzhou Siyao Pharmaceutical
  32. 6.6.1 Changzhou Siyao Pharmaceutical Company Information
  33. 6.6.2 Changzhou Siyao Pharmaceutical Business Overview
  34. 6.6.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio
  36. 6.6.5 Changzhou Siyao Pharmaceutical Recent Developments
  37. 6.7 Astrazeneca
  38. 6.7.1 Astrazeneca Company Information
  39. 6.7.2 Astrazeneca Business Overview
  40. 6.7.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio
  42. 6.7.5 Astrazeneca Recent Developments
7 North America by Country
  1. 7.1 North America Felodipine Sustained-Release Tablet Sales by Country
  2. 7.1.1 North America Felodipine Sustained-Release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Felodipine Sustained-Release Tablet Sales by Country (2021-2026)
  4. 7.1.3 North America Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032)
  5. 7.2 North America Felodipine Sustained-Release Tablet Market Size by Country
  6. 7.2.1 North America Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Felodipine Sustained-Release Tablet Market Size by Country (2021-2026)
  8. 7.2.3 North America Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Felodipine Sustained-Release Tablet Sales by Country
  2. 8.1.1 Europe Felodipine Sustained-Release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Felodipine Sustained-Release Tablet Sales by Country (2021-2026)
  4. 8.1.3 Europe Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Felodipine Sustained-Release Tablet Market Size by Country
  6. 8.2.1 Europe Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Felodipine Sustained-Release Tablet Market Size by Country (2021-2026)
  8. 8.2.3 Europe Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales by Country
  2. 9.1.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Felodipine Sustained-Release Tablet Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Country
  6. 9.2.1 Asia-Pacific Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Felodipine Sustained-Release Tablet Sales by Country
  2. 10.1.1 South America Felodipine Sustained-Release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Felodipine Sustained-Release Tablet Sales by Country (2021-2026)
  4. 10.1.3 South America Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032)
  5. 10.2 South America Felodipine Sustained-Release Tablet Market Size by Country
  6. 10.2.1 South America Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Felodipine Sustained-Release Tablet Market Size by Country (2021-2026)
  8. 10.2.3 South America Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country
  2. 11.1.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Felodipine Sustained-Release Tablet Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country
  6. 11.2.1 Middle East and Africa Felodipine Sustained-Release Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Felodipine Sustained-Release Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Felodipine Sustained-Release Tablet Value Chain Analysis
  2. 12.1.1 Felodipine Sustained-Release Tablet Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Felodipine Sustained-Release Tablet Production Mode & Process
  7. 12.2 Felodipine Sustained-Release Tablet Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Felodipine Sustained-Release Tablet Distributors
  10. 12.2.3 Felodipine Sustained-Release Tablet Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst